Product Categories
| Country: | China |
|---|---|
| Tel: | |
| Mobile: | +8615002134094 |
| E-mail: | marketing@targetmol.cn |
| QQ: | 2881954871 |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| P-CAB agent 1 | C26H23FN4O | 2374139-68-9 | Details |
| HPK1-IN-30 | C25H23FN6 | 2700292-56-2 | Details |
| CSF1R-IN-9 | C26H26N4O2 | 2765301-84-4 | Details |
| α7 nAchR-JAK2-STAT3 agonist 1 | C25H30O6 | 2108714-20-9 | Details |
| (S)-MALT1-IN-5 | C17H17ClF2N6O3 | 2434602-25-0 | Details |
| CSF1R-IN-10 | C25H22N4O3 | 2765301-88-8 | Details |
| VEGFR-2-IN-25 | C24H22N6O2 | 2439096-02-1 | Details |
| Estrogen receptor β antagonist 2 | C23H26N2O6 | 2580941-14-4 | Details |
| Antiviral agent 14 | C24H26O7 | 2755814-80-1 | Details |
| Human enteropeptidase-IN-1 | C20H18N4O7 | 1802891-23-1 | Details |
| J-1063 | C24H19N5OS | 2374772-46-8 | Details |
| PHD2/HDACs-IN-1 | C18H19N9O4 | 2339867-53-5 | Details |
| Factor B-IN-2 | C25H32N2O4 | 2760669-72-3 | Details |
| ALK5-IN-28 | C25H27N7 | 2785430-84-2 | Details |
| Antimalarial agent 11 | C25H25F2NO3 | 1214454-56-4 | Details |
| MMV688844 | C23H25ClN4O2 | 2650213-59-3 | Details |
| FWM-4 | C24H18N4O4 | 2757194-03-7 | Details |
| TRK-IN-21 | C22H22F2N6O | 2429985-55-5 | Details |
| PPARδ agonist 8 | C25H29NO5 | 2697129-55-6 | Details |
| SARS-CoV-2 nsp13-IN-2 | C20H18N6OS2 | 522660-61-3 | Details |
| COX-2-IN-21 | C21H22N6O4 | 2519631-11-7 | Details |
| Neuroinflammatory-IN-2 | C25H27FN2O3 | 2361384-14-5 | Details |
| γ-Secretase modulator 13 | C22H23FN6S | 1353570-40-7 | Details |
| IDO-IN-14 | C23H23ClN4O2 | 2568302-02-1 | Details |
| AChE/BChE-IN-2 | C23H25N3O5 | 2761991-42-6 | Details |
| HBV-IN-11 | C21H24ClNO6 | 2226178-41-0 | Details |
| μ opioid receptor agonist 1 | C26H38N4O | 2667632-83-7 | Details |
| JAK3/BTK-IN-3 | C22H28N8O | 2674036-98-5 | Details |
| TLR9-IN-1 | C23H31N7O | 2226366-86-3 | Details |
| Cdc7-IN-11 | C20H22F2N4O2S | 2649409-19-6 | Details |
| Retezorogant | C23H33ClN2O3 | 1950570-48-5 | Details |
| HBV-IN-9 | C22H24FN7O | 2170998-69-1 | Details |
| Cdc7-IN-10 | C20H22F2N4O2S | 2649409-20-9 | Details |
| Bcl-2/Mcl-1-IN-1 | C28H23NO3 | 2673361-08-3 | Details |
| SARS-CoV-2 nsp13-IN-6 | C21H19N5O3S | 951588-85-5 | Details |
| HSR1304 | C24H21ClN2O3 | 2763363-08-0 | Details |
| ATR-IN-10 | C27H24N4O | 2713577-93-4 | Details |
| α-Glucosidase-IN-11 | C23H20N2O6 | 2411744-76-6 | Details |
| Topoisomerase IIα-IN-1 | C22H20N4O5 | 2407521-87-1 | Details |
| Influenza virus-IN-5 | C21H26ClN3O2S | 2581825-57-0 | Details |
| Tubulin polymerization-IN-9 | C19H19NO5Se | 2485020-93-5 | Details |
| Antitrypanosomal agent 4 | C18H14ClN3O5S | 2456427-48-6 | Details |
| Topoisomerase IIα-IN-2 | C22H20N4O5 | 2407521-90-6 | Details |
| Antifungal agent 33 | C21H14ClN5O3 | 2445277-57-4 | Details |
| Antileishmanial agent-10 | C25H41NO2S | 2397639-33-5 | Details |
| Pparδ agonist 7 | C25H25NO5 | 2340432-40-6 | Details |
| AR524 | C26H30N2O3 | 2568148-31-0 | Details |
| PD-1/PD-L1-IN 5 | C22H18N4O3S | 2170209-51-3 | Details |
| Analgesic agent-1 | C23H19FN4OS | 2230243-92-0 | Details |
| CDK9-IN-14 | C21H23F2N3O4 | 2650640-17-6 | Details |
| TRPC6-IN-2 | C19H17Cl2FN6 | 2308595-83-5 | Details |
| CEP-9722 | C24H26N4O3 | 916574-83-9 | Details |
| Influenza virus-IN-4 | C23H31FN2O4 | 2133818-85-4 | Details |
| DNA-PK-IN-5 | C21H22N8O2 | 2719736-43-1 | Details |
| CDK4/6-IN-9 | C22H23FN8 | 2688098-02-2 | Details |
| GABA-AT-IN-1 | C23H18N2O6 | 242148-96-5 | Details |
| PIM1-IN-6 | C21H18N6O4 | 2439168-69-9 | Details |
| NIC-0102 | C21H25BF2N2O4 | 2806031-94-5 | Details |
| NRX-2663 | C20H13F3N2O5 | 2763260-34-8 | Details |
| CDK2-IN-11 | C18H14ClN7O2S | 2410402-82-1 | Details |
| Antileishmanial agent-12 | C25H21N3O4 | 2482764-71-4 | Details |
| Tubulin inhibitor 13 | 2883436-66-4 | Details |
| IMPDH2-IN-2 | C21H15Cl2N3O3 | 1434517-02-8 | Details |
| MALT1-IN-5 | C17H17ClF2N6O3 | 2434602-73-8 | Details |
| FGFR-IN-6 | C23H22N6O3 | 2762955-18-8 | Details |
| PI3K-IN-34 | C23H22N6O3 | 2458163-94-3 | Details |
| CSF1R-IN-8 | C24H22N4O4 | 2765301-60-6 | Details |
| 14α-Demethylase/DNA Gyrase-IN-2 | C24H22N4O4 | 2330812-64-9 | Details |
| Anti-MRSA agent 2 | 2597082-01-2 | Details |
| SARS-CoV-2 nsp13-IN-3 | C24H27N7O | 1015582-31-6 | Details |
| S07-2008 | C21H23N3O5S | 1090816-80-0 | Details |
| Antitrypanosomal agent 8 | C23H19N5O2S | 332376-42-8 | Details |
| SOS1-IN-12 | C23H26F3N5 | 2654741-56-5 | Details |
| Nivasorexant | C23H23N7O2 | 1435480-40-2 | Details |
| Tubulin polymerization-IN-17 | C26H23NO5 | 2454175-89-2 | Details |
| Enpp-1-IN-4 | C19H19N5O5S | 2376600-89-2 | Details |
| CSF1R-IN-5 | C22H19N7O3 | 2716184-93-7 | Details |
| GNF6702 | C22H16FN7O2 | 1799329-72-8 | Details |
| HBV-IN-14 | C22H21ClN2O5 | 2712529-19-4 | Details |
| CDK8-IN-7 | C30H40N2 | 2415156-30-6 | Details |
| CXCR4 modulator-2 | C21H32N8O2 | 2488943-55-9 | Details |
| A1AR antagonist 3 | C25H20N2O3S | 2413257-73-3 | Details |
| MPO-IN-5 | C24H24N6O2 | 2476764-11-9 | Details |
| MIF-IN-3 | C20H20N4O5S | 2756410-83-8 | Details |
| NBD-14189 | C18H16F4N4O2S | 2234273-72-2 | Details |
| EGFR-IN-40 | C23H20N6O3 | 1466445-39-5 | Details |
| TLR7/8 agonist 6 | C24H27N5O2 | 2115702-83-3 | Details |
| HDAC8/BRPF1-IN-1 | C19H19N3O6S | 2484255-85-6 | Details |
| CSF1R-IN-4 | C23H20N6O3 | 2716185-86-1 | Details |
| CSF1R-IN-6 | C20H18N8O3 | 2716184-87-9 | Details |
| CSF1R-IN-7 | C22H22N6O3 | 2738328-56-6 | Details |
| Tubulin polymerization-IN-19 | C25H25NO5 | 2340345-85-7 | Details |
| mGluR2 modulator 1 | C21H20F3N3O3 | 2671063-84-4 | Details |
| Cap-dependent endonuclease-IN-6 | C23H21N3O3S | 2489248-15-7 | Details |
| GP3269 | C23H21FN4O3 | 186393-42-0 | Details |
| Sirt1/2-IN-1 | C22H13ClN2OS2 | 2402779-21-7 | Details |
| GPVI antagonist 2 | C24H27N3O4 | 880399-00-8 | Details |
| Factor B-IN-3 | C24H29N3O4 | 2760669-74-5 | Details |
| Anti-inflammatory agent 21 | C24H21FO6 | 2408836-40-6 | Details |
| Product Total： Product Page： | ||||
| 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 | ||||